broker's calls

In its Singapore Equity Picks report dated April 16, the team at DBS Group Research says it has turned “net seller” in the past month to capitalise on the “dividend-driven” rally in March to April

DBS Group Research has downgraded Singapore Airlines (SIA) to “fully valued” with a target price of $3.60 that’s based on 0.9 times FY2022 price-to-book (P/BV).

OCBC Investment Research analyst Chu Peng is recommending investors continue to “hold” onto Singapore Post (SingPost) with an increased fair value estimate of 74 cents from 71 cents.

DBS Group Research analysts Ling Lee Keng and Chung Wei Le have initiated “buy” on GHY Culture & Media Holding with a target price of $1.

PhillipCapital analyst Natalie Ong has maintained her “overweight” outlook on Singapore REITs (S-REITs) amid catalysts expected from the pick-up in the Singapore economy.

UOB Kay Hian analyst K Ajith has downgraded Singapore Airlines (SIA) to “sell” with a lower target price of $4.40 from $4.43 previously.

As dimethylformamide (DMF) prices continue on a strong uptrend year-to-date (y-t-d), CGS-CIMB Research analysts Ong Khang Chuen and Kenneth Tan estimate that Jiutian Chemical Group will post a “rec

UOB Kay Hian analysts John Cheong and Clement Ho are remaining positive on Sunpower Group following its record PATMI in 2020.

RHB Group Research analyst Vijay Natarajan has initiated coverage on AIMS APAC REIT (AA REIT) with a “buy” recommendation and a target price of $1.55, the highest among all the other estimates put

iX Biopharma remains a “buy” for PhillipCapital analyst Tay Wee Kuang, with an unchanged target price of 44.5 cents, as the specialty pharmaceutical company announced that it has entered into a str